Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity

Immunology

Volumn 130, Issue 1, 2010, Pages 46-54

  Chai, Louis Y A ^a,b   Van De Veerdonk, Frank ^a   Marijnissen, Renoud J ^a   Cheng, Shih Chin ^a   Khoo, Ai Leng ^a   Hectors, Magda ^a   Lagrou, Katrien ^c   Vonk, Alieke G ^d   Maertens, Johan ^c   Joosten, Leo A B ^a   Kullberg, Bart Jan ^a   Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Aspergillus; Interferon ; Interleukin 17; Kynurenine; Macrophages

Indexed keywords

INTERLEUKIN 17; KYNURENINE; TRYPTOPHAN;

ARTICLE; ASPERGILLUS FUMIGATUS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; LUNG ASPERGILLOSIS; LUNG LAVAGE; MACROPHAGE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS INHIBITION; TH1 CELL; TH17 CELL;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-17; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS;

EID: 77950500877     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03211.x     Document Type: Article

References (47)

1. Patterson TF, Kirkpatrick WR, White M et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. Aspergillus Study Group. Medicine (Balt) 2000 79 : 250 260.
2. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998 26 : 781 803.
3. Stevens DA. Th1/Th2 in aspergillosis. Med Mycol 2006 1 : 229 235.
4. Romani L. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 1999 2 : 363 367.
5. Chai LY, Netea MG, Vonk AG, Kullberg BJ. Fungal strategies for overcoming host innate immune response. Med Mycol 2009 47 : 227 236.
6. Netea MG, Van der Meer JW, Sutmuller RP, Adema GJ, Kullberg BJ. From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob Agents Chemother 2005 49 : 3991 3996.
7. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005 6 : 1123 1132.
8. Bettelli E, Korn T, Oukka M, Kuchroo VK. Induction and effector functions of Th17 cells. Nature 2008 453 : 1051 1057.
9. Awasthi A, Kuchroo VK. Th17 cells: from precursors to players in inflammation and infection. Int Immunol 2009 21 : 489 498.
10. Dong C. Th17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008 8 : 337 348.
11. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004 21 : 467 476.
12. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004 190 : 624 631.
13. Romagnani S, Maggi E, Liotta F, Cosmi L, Annunziato F Properties and origin of human Th17 cells. Mol Immunol 2009 47 : 3 7.
14. Romagnani S. Human Th17 cells. Arthritis Res Ther 2008 10 : 206.
15. Zelante T, De Luca A, Bonifazi P et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007 37 : 2695 2706.
16. Werner JL, Metz AE, Horn D et al. Requisite role for the dectin-1 β-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 2009 182 : 4938 4946.
17. Netea MG, Warris A, Van der Meer JW et al. Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction. J Infect Dis 2003 188 : 320 326.
18. Chai LY, Kullberg BJ, Vonk AG et al. Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect Immun 2009 77 : 2184 2192.
19. Tsai HF, Chang YC, Washburn RG, Wheeler MH, Kwon-Chung KJ. The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence. J Bacteriol 1998 180 : 3031 3038.
20. Gersuk GM, Underhill DM, Zhu L, Marr KA. Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol 2006 176 : 3717 3724.
21. Gow NA, Netea MG, Munro CA et al. Immune recognition of Candida albicansβ-glucan by dectin-1. J Infect Dis 2007 196 : 1565 1571.
22. Lehrer RI, Cline MJ. Interaction of Candida albicans with human leukocytes and serum. J Bacteriol 1969 98 : 996 1004.
23. Netea MG, Gow NA, Munro CA et al. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J Clin Invest 2006 116 : 1642 1650.
24. Ferwerda G, Meyer-Wentrup F, Kullberg BJ, Netea MG, Adema GJ. Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell Microbiol 2008 10 : 2058 2066.
25. van de Veerdonk FL, Marijnissen RJ, Kullberg BJ et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009 5 : 329 340.
26. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002 347 : 408 415. (Pubitemid 34851833)
27. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008 46 : 1813 1821.
28. Zucchelli GC, Pilo A, Chiesa MR, Cohen R, Bizollon CA. Analytical performance of free PSA immunoassays: results from an interlaboratory survey. Clin Chem 1997 43 : 2426 2428.
29. Krstulovic AM, Friedman MJ, Colin H, Guiochon G, Gaspar M, Pajer KA. Analytical methodology for assays of serum tryptophan metabolites in control subjects and newly abstinent alcoholics: preliminary investigation by liquid chromatography with amperometric detection. J Chromatogr 1984 297 : 271 281. (Pubitemid 14074896)
30. Rivera A, Ro G, Van Epps HL, Simpson T, Leiner I, Sant'Angelo DB, Pamer EG. Innate immune activation and CD4+ T cell priming during respiratory fungal infection. Immunity 2006 25 : 665 675.
31. Zelante T, Bozza S, De Luca A et al. Th17 cells in the setting of Aspergillus infection and pathology. Med Mycol 2009 47 (Suppl. 1 S162 9.
32. Romani L, Zelante T, De Luca A et al. Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus. Med Mycol 2009 47 (Suppl. 1 S154 61.
33. Romani L, Zelante T, De Luca A, Fallarino F, Puccetti P. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 2008 180 : 5157 5162.
34. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007 8 : 942 949.
35. Chen Z, Tato CM, Muul L, Laurence A, O'Shea JJ. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 2007 56 : 2936 2946.
36. Steele C, Rapaka RR, Metz A, Pop SM, Williams DL, Gordon S, Kolls JK, Brown GD. The β-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog 2005 1 : e42.
37. + regulatory T cells differentiate into IL-17-producing cells. Blood 2008 112 : 2340 2352.
38. Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007 8 : 950 957.
39. Hebart H, Bollinger C, Fisch P et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood 2002 100 : 4521 4528.
40. Xu H, Oriss TB, Fei M et al. Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation. Proc Natl Acad Sci USA 2008 105 : 6690 6695.
41. Kong QF, Sun B, Wang GY et al. BM stromal cells ameliorate experimental autoimmune myasthenia gravis by altering the balance of Th cells through the secretion of IDO. Eur J Immunol 2009 39 : 800 809.
42. Kanehisa Laboratories UoK, Japan. Tryptophan metabolism -Aspergillus fumigatus, Vol. 2009.
43. LeibundGut-Landmann S, Gross O, Robinson MJ et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 2007 8 : 630 638.
44. Zelante T, De Luca A, D'Angelo C, Moretti S, Romani L. IL-17/Th17 in anti-fungal immunity: what's new? Eur J Immunol 2009 39 : 645 648.
45. Holland SM, DeLeo FR, Elloumi HZ et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007 357 : 1608 1619.
46. Ma CS, Chew GY, Simpson N et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008 205 : 1551 1557.
47. Freeman AF, Holland SM. The hyper-IgE syndromes. Immunol Allergy Clin North Am 2008 28 : 277 291.